A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza

NCT00706732 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: AVX502
BIOLOGICAL: AVX502
BIOLOGICAL: Placebo
BIOLOGICAL: Placebo

Sponsor

AlphaVax, Inc.